High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment
Productumnomen | AZD-9291 mesylate |
Synonyma | N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]- 2-propenamide methanesulfonate (1:1) |
CAS Non. | 1421373-66-1 |
Aspectus | Alba ut lux flavo solidum pulveris |
Formulae hypotheticae | C28H33N7O2.CH4O3S |
M. Pondus | 595.71 |
Consuetudinem | Pharmaceutical Grade vel Research proposito |
stipare | Quod per petitio tua |
Repono | Serva in stricta, levis vasis repugnans in loco frigido |
AZD-9291 mesylateCAS:1421373-66-1 | ||
Items | Standards | Results |
Aspectus | Alba ut lux flavo solidum pulveris | Lumen luteum solidum pulveris |
Identification | per IR | Obsequitur |
per HPLC | Obsequitur | |
Solubilitas | Solubile in Dimethylsulfoxide, leviter solutum in Ethanol et Acetonitrile, cum pH dependens aqueum solubilitatem. | Obsequitur |
Aqua Contenta (KF) | ≤ 1.00% | 0.42% |
Residere in Ignition | ≤ 0.10% | 0.05% |
HeavyMetal | ≤ 20ppm | Obsequitur |
Mesylate | 15.20%~ 18.20% | 15.90% |
RELICTUM Solvents | Acetonitrile: ≤410ppm | ND |
Acetone: ≤5000ppm | ND | |
Tetrahydrofuran: ≤720ppm | ND | |
RelatusSubstances | Maximum unius immunditiae: ≤0.20% | 0.17% |
Totalis immunditiae: ≤1.00% | 0.25% | |
Magnitudo particula | D90: ≤100μm | 57.97% |
Asay (HPLC basis in siccitate) | 98.00%~ 102.00% | 99.80% |
Reference Standard | In-domus Latin |
Company Information
√ Procuratio accumsan plena experientia in technicis et technicis peritissimis sectatoribus; √ Quality is always our top consideration, Strict QC system; √ 11 annos periti quadrigis venditio educendi; √ Independentes R&D lab; √ Duae officinae GMP terminus signati longi sunt; √ Divites copiarum otiosorum officinarum copia pro project nativus; √ High Efficiency working team with consistent path.Epistulam tuam hic scribe et mitte nobis